In our population, the most common diagnoses that made up this group were other primary thrombophilia (D68.59), other thrombophilia (D68.69), coagulation defect, unspecified (D68.9), activated protein C resistance (D68.51), antiphospholipid syndrome (D68.61), lupus anticoagulant syndrome (D68.62), hemorrhagic disorder due to extrinsic circulating anticoagulants (D68.32), and prothrombin gene mutation (D68.52). This evidence concerns the gene F2 and antiphospholipid syndrome.